Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
N414442-1mg
|
1mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$98.90
|
|
|
N414442-5mg
|
5mg |
2
|
$345.90
|
|
|
N414442-10mg
|
10mg |
3
|
$573.90
|
|
|
N414442-25mg
|
25mg |
2
|
$1,291.90
|
|
|
N414442-50mg
|
50mg |
2
|
$1,632.90
|
|
Histone Acetyltransferase Inhibitors
| Synonyms | EP316702 | 1,3-dimethyl-5-[2-(tetrahydro-2H-pyran-4-yl)-1-[2-(trifluoromethoxy)ethyl]-1H-benzimidazol-6-yl]- (1H)-Pyridinone |
|---|---|
| Specifications & Purity | ≥98% |
| Biochemical and Physiological Mechanisms | NEO2734 (EP31670) is a novel, orally active and selective dual inhibitor of p300/CBP and BET bromodomain with IC50 of both <30 nM. |
| Storage Temp | Store at -20°C |
| Shipped In |
Ice chest + Ice pads This product requires cold chain shipping. Ground and other economy services are not available. |
| Product Description |
Information NEO2734 NEO2734 (EP31670) is a novel, orally active and selective dual inhibitor of p300/CBP and BET bromodomain with IC50 of both <30 nM. Targets p300/CBP (Cell-free assay); BET (Cell-free assay) <30 nM; <30 nM In vitro Treatment of NMC cells with the novel dual p300/CBP and BET bromodomain–selective inhibitor, NEO2734, potently inhibits growth and induces differentiation of NMC cells in vitro; findings that correspond with potentiated transcriptional effects from combined BET and p300 bromodomain inhibition. In vivo In three disseminated NMC xenograft models, NEO2734 provides greater growth inhibition, with tumor regression and significant survival benefit seen in two of three models, compared with a lead clinical BET inhibitor or “standard” chemotherapy. Cell Research(from reference) Cell lines:NUT carcinoma patient cell lines (TC-797, 14169, 10-15, PER-403) Concentrations:1 μM Incubation Time:24 h |
| Pubchem Sid | 504773015 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/504773015 |
| IUPAC Name | 1,3-dimethyl-5-[2-(oxan-4-yl)-3-[2-(trifluoromethoxy)ethyl]benzimidazol-5-yl]pyridin-2-one |
| INCHI | InChI=1S/C22H24F3N3O3/c1-14-11-17(13-27(2)21(14)29)16-3-4-18-19(12-16)28(7-10-31-22(23,24)25)20(26-18)15-5-8-30-9-6-15/h3-4,11-13,15H,5-10H2,1-2H3 |
| InChIKey | KPWWFNXRLAAREN-UHFFFAOYSA-N |
| Smiles | CC1=CC(=CN(C1=O)C)C2=CC3=C(C=C2)N=C(N3CCOC(F)(F)F)C4CCOCC4 |
| Molecular Weight | 435.44 |
| Reaxy-Rn | 30909951 |
| Reaxys-RN_link_address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=30909951&ln= |
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Apr 03, 2025 | N414442 | |
| Certificate of Analysis | Apr 03, 2025 | N414442 | |
| Certificate of Analysis | Apr 03, 2025 | N414442 | |
| Certificate of Analysis | Apr 03, 2025 | N414442 |
| Solubility | Solubility (25°C) In vitro DMSO: 87 mg/mL (199.79 mM); Ethanol: 87 mg/mL (199.79 mM); Water: Insoluble; |
|---|---|
| Molecular Weight | 435.400 g/mol |
| XLogP3 | 2.900 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 5 |
| Exact Mass | 435.177 Da |
| Monoisotopic Mass | 435.177 Da |
| Topological Polar Surface Area | 56.600 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 733.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |